A Podcast for Cancer Survivors

with

Loriana Hernández-Aldama

Award-winning journalist

2x cancer survivor

[Listen now](/content/us/human-health/cancer/stage-free-podcast-cancer-community "FDA Approves Targeted Therapy for Patients with HER2-Mutant Advanced Non-Small Cell Lung Cancer as an Initial Treatment"/index.html)

Innovation and growth drive first-half 2026 performance

Boehringer advances three Phase III trials in oncology

Bridging vet care deserts amid New World screwworm

Veterinary care gaps can hinder response to New World screwworm. Learn how Boehringer Cares helps communities prepare.

Full data from two Phase III SYNCHRONIZE obesity trials

Brain metastases in NSCLC: Risks, symptoms, and early detection

Learn why people with NSCLC face a higher risk of brain metastases, the symptoms to watch for, and why early monitoring can make a meaningful difference.

How biomarker testing guides lung cancer care

Learn how biomarker testing can help guide treatment decisions for non-small cell lung cancer.

New research across Boehringer’s oncology portfolio will be presented at ASCO 2026

A collective path to healthier futures

Boehringer Ingelheim’s Christie Bloomquist on the value of prioritizing early detection and disease management.

Our science and innovation

We are driven by science and seek to push the boundaries of what’s possible in medicine and explore new options in life-enhancing treatments.

Partner with us

Partnerships are the lifeblood of our organization. We cultivate partnerships that push our clinical boundaries further in the pursuit of disruptive ideas, compounds and technologies that will help reshape human and animal healthcare for tomorrow.

Boehringer Ingelheim Cares Foundation

The Boehringer Ingelheim Cares Foundation is an independent, nonprofit organization with a mission to strengthen communities by improving the health and well-being of people and animals.

Being part of a global family

Join us to grow, collaborate, innovate and improve lives.